Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

372 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Teprotumumab for the treatment of thyroid eye disease.
Fallahi P, Ragusa F, Paparo SR, Elia G, Balestri E, Mazzi V, Patrizio A, Botrini C, Benvenga S, Ferrari SM, Antonelli A. Fallahi P, et al. Among authors: benvenga s. Expert Opin Biol Ther. 2023 Feb;23(2):123-131. doi: 10.1080/14712598.2023.2172328. Epub 2023 Jan 29. Expert Opin Biol Ther. 2023. PMID: 36695097
Lenvatinib: an investigational agent for the treatment of differentiated thyroid cancer.
Ferrari SM, Elia G, Ragusa F, Paparo SR, Mazzi V, Miccoli M, Galdiero MR, Varricchi G, Foddis R, Guglielmi G, Spinelli C, La Motta C, Benvenga S, Antonelli A, Fallahi P. Ferrari SM, et al. Among authors: benvenga s. Expert Opin Investig Drugs. 2021 Sep;30(9):913-921. doi: 10.1080/13543784.2021.1972971. Epub 2021 Sep 6. Expert Opin Investig Drugs. 2021. PMID: 34428101 Review.
Antithyroid medications and psychosis.
Vita R, Mazzi V, Antonelli A, Benvenga S. Vita R, et al. Among authors: benvenga s. Expert Opin Drug Saf. 2013 Nov;12(6):865-72. doi: 10.1517/14740338.2013.823397. Epub 2013 Jul 25. Expert Opin Drug Saf. 2013. PMID: 23883069 Review.
Thyroid dysfunctions induced by tyrosine kinase inhibitors.
Fallahi P, Ferrari SM, Vita R, Di Domenicantonio A, Corrado A, Benvenga S, Antonelli A. Fallahi P, et al. Among authors: benvenga s. Expert Opin Drug Saf. 2014 Jun;13(6):723-33. doi: 10.1517/14740338.2014.913021. Epub 2014 May 12. Expert Opin Drug Saf. 2014. PMID: 24821006 Review.
Personalization of targeted therapy in advanced thyroid cancer.
Fallahi P, Ferrari SM, Mazzi V, Vita R, Benvenga S, Antonelli A. Fallahi P, et al. Among authors: benvenga s. Curr Genomics. 2014 Jun;15(3):190-202. doi: 10.2174/1389202915999140404101902. Curr Genomics. 2014. PMID: 24955027 Free PMC article.
Selective use of vandetanib in the treatment of thyroid cancer.
Fallahi P, Di Bari F, Ferrari SM, Spisni R, Materazzi G, Miccoli P, Benvenga S, Antonelli A. Fallahi P, et al. Among authors: benvenga s. Drug Des Devel Ther. 2015 Jul 3;9:3459-70. doi: 10.2147/DDDT.S72495. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26170630 Free PMC article. Review.
Novel Therapies for Thyroid Autoimmune Diseases.
Fallahi P, Ferrari SM, Elia G, Nasini F, Colaci M, Giuggioli D, Vita R, Benvenga S, Ferri C, Antonelli A. Fallahi P, et al. Among authors: benvenga s. Expert Rev Clin Pharmacol. 2016 Jun;9(6):853-61. doi: 10.1586/17512433.2016.1157468. Epub 2016 Mar 8. Expert Rev Clin Pharmacol. 2016. PMID: 26900630 Review.
372 results